Projection of the number of new cases of skin cancer in the world.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 945, doi. 10.1093/jjco/hyae097
- By:
- Publication type:
- Article
Works matching IS 03682811 AND DT 2024 AND VI 54 AND IP 8
Results: 14
1
2
Development of an evaluation and treatment strategy for olfactory neuroblastoma: a review of evidence from large-scale studies, including population-based and multicenter studies, and meta-analyses.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 847, doi. 10.1093/jjco/hyae062
- By:
- Publication type:
- Article
3
Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph<sup>+</sup> ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 930, doi. 10.1093/jjco/hyae061
- By:
- Publication type:
- Article
4
Incidence and risk factors of PICC-related thrombosis in breast cancer: a meta-analysis.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 863, doi. 10.1093/jjco/hyae055
- By:
- Publication type:
- Article
5
Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatments.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 887, doi. 10.1093/jjco/hyae060
- By:
- Publication type:
- Article
6
Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 895, doi. 10.1093/jjco/hyae058
- By:
- Publication type:
- Article
7
Evaluation of PET/CT imaging with [<sup>89</sup>Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 873, doi. 10.1093/jjco/hyae075
- By:
- Publication type:
- Article
8
Surgical approach through the anterior scalene muscle resection for invasive tumours in the supraclavicular fossa (with video).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 939, doi. 10.1093/jjco/hyae057
- By:
- Publication type:
- Article
9
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 926, doi. 10.1093/jjco/hyae056
- By:
- Publication type:
- Article
10
Antibody-drug conjugates in solid tumors; new strategy for cancer therapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 837, doi. 10.1093/jjco/hyae054
- By:
- Publication type:
- Article
11
Clinical characteristics and prognosis of patients with incidentally discovered chest wall sarcoma compared with those of symptomatic patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 911, doi. 10.1093/jjco/hyae059
- By:
- Publication type:
- Article
12
Embryonal and alveolar rhabdomyosarcoma in adolescents/young adults, adults and older adults: a population-based cohort study.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 903, doi. 10.1093/jjco/hyae053
- By:
- Publication type:
- Article
13
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 880, doi. 10.1093/jjco/hyae052
- By:
- Publication type:
- Article
14
Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 917, doi. 10.1093/jjco/hyae051
- By:
- Publication type:
- Article